The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Treatment of symptomatic diabetic polyneuropathy with the antioxidant α‐lipoic acid: a meta‐analysis
Abstract
Aims To determine the efficacy and safety of 600 mg of α‐lipoic acid given intravenously over 3 weeks in diabetic patients with symptomatic polyneuropathy. Methods We searched the database of VIATRIS GmbH, Frankfurt, Germany, for clinical trials of α‐lipoic acid according to the following prerequisites: randomized, double‐masked, placebo‐controlled, parallel‐group trial using α‐lipoic acid infusions of 600 mg i.v. per day for 3 weeks, except for weekends, in diabetic patients with positive sensory symptoms of polyneuropathy which were scored by the Total Symptom Score (TSS) in the feet on a daily basis. Four trials (ALADIN I, ALADIN III, SYDNEY, NATHAN II) comprised n = 1258 patients (α‐lipoic acid n = 716; placebo n = 542) met these eligibility criteria and were included in a meta‐analysis based on the intention‐to‐treat principle. Primary analysis involved a comparison of the differences in TSS from baseline to the end of i.v. Treatment between the groups treated with α‐lipoic acid or placebo. Secondary analyses included daily changes in TSS, responder rates (≥ 50% improvement in TSS), individual TSS components, Neuropathy Impairment Score (NIS), NIS of the lower limbs (NIS‐LL), individual NIS‐LL components, and the rates of adverse events. Results After 3 weeks the relative difference in favour of α‐lipoic acid vs. placebo was 24.1% (13.5, 33.4) (geometric mean with 95% confidence interval) for TSS and 16.0% (5.7, 25.2) for NIS‐LL. The responder rates were 52.7% in patients treated with α‐lipoic acid and 36.9% in those on placebo (P < 0.05). On a daily basis there was a continuous increase in the magnitude of TSS improvement in favour of α‐lipoic acid vs. placebo which was noted first after 8 days of treatment. Among the individual components of the TSS, pain, burning, and numbness decreased in favour of α‐lipoic acid compared with placebo, while among the NIS‐LL components pin‐prick and touch‐pressure sensation as well as ankle reflexes were improved in favour of α‐lipoic acid after 3 weeks. The rates of adverse events did not differ between the groups. Conclusions The results of this meta‐analysis provide evidence that treatment with α‐lipoic acid (600 mg/day i.v.) over 3 weeks is safe and significantly improves both positive neuropathic symptoms and neuropathic deficits to a clinically meaningful degree in diabetic patients with symptomatic polyneuropathy. Diabet. Med. 21, 114–121 (2004)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Young, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
meta-analysis bias in location and selection of studies
Egger, M., & Smith, G. D. (1998) · BMJ · doi:10.1136/bmj.316.7124.61 · Cited by 1,374
Publication bias: evidence of delayed publication in a cohort study of clinical research projects
Stern, J. M., & Simes, R. J. (1997) · BMJ · doi:10.1136/bmj.315.7109.640 · Cited by 818
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy
Cameron, N. E., Eaton, S. E. M., Cotter, M. A., & Tesfaye, S. (2001) · Diabetologia · doi:10.1007/s001250100001 · Cited by 701
Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life
Galer, B. S., Gianas, A., & Jensen, M. P. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00112-6 · Cited by 601
Ziegler, D., Hanefeld, M., Ruhnau, K. J., Mei\ner, H. P., Lobisch, M., Sch�tte, K., Gries, F. A., & The ALADIN Study Group (1995) · Diabetologia · doi:10.1007/bf00400603 · Cited by 525
Self-citationHuman diabetic endoneurial sorbitol, fructose, and myo‐inositol related to sural nerve morphometry
Dyck, P. J., Sherman, W. R., Hallcher, L. M., John Service, F., O'Brien, P. C., Grina, L. A., Palumbo, P. J., & Swanson, C. J. (1980) · Annals of Neurology · doi:10.1002/ana.410080608 · Cited by 511
The Roles of Oxidative Stress and Antioxidant Treatment in Experimental Diabetic Neuropathy
Low, P. A., Nickander, K. K., & Tritschler, H. J. (1997) · Diabetes · doi:10.2337/diab.46.2.s38 · Cited by 432
Self-citationZiegler, D., Hanefeld, M., Ruhnau, K. J., Hasche, H., Lobisch, M., Schütte, K., Kerum, G., & Malessa, R. (1999) · Diabetes Care · doi:10.2337/diacare.22.8.1296 · Cited by 432
Self-citationAbbott, C. A., Vileikyte, L., Williamson, S., Carrington, A. L., & Boulton, A. J. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1071 · Cited by 399
Dyck, P. J., Davies, J. L., Litchy, W. J., & O'Brien, P. C. (1997) · Neurology · doi:10.1212/wnl.49.1.229 · Cited by 382
Nagamatsu, M., Nickander, K. K., Schmelzer, J. D., Raya, A., Wittrock, D. A., Tritschler, H., & Low, P. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.8.1160 · Cited by 378
Self-citationThe Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid
The SYDNEY Trial Authors, F. T. S. T. S. G., Ametov, A. S., Barinov, A., Dyck, P. J., Hermann, R., Kozlova, N., Litchy, W. J., Low, P. A., Nehrdich, D., Novosadova, M., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.770 · Cited by 359
Self-citationCoppey, L. J., Gellett, J. S., Davidson, E. P., Dunlap, J. A., Lund, D. D., & Yorek, M. A. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1927 · Cited by 300
Ziegler, D., Reljanovic, M., Mehnert, H., & Gries, F. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212132 · Cited by 220
Self-citationHeitzer, T. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00551-2 · Cited by 194
Meta-analysis: Unresolved issues and future developments
Smith, G. D., & Egger, M. (1998) · BMJ · doi:10.1136/bmj.316.7126.221 · Cited by 175
Cameron, N. E., Cotter, M. A., Horrobin, D. F., & Tritschler, H. (1998) · Diabetologia · doi:10.1007/s001250050921 · Cited by 156
Borcea, V., Nourooz‐Zadeh, J., Wolff, S. P., Klevesath, M. S., Hofmann, M. A., Urich, H., Wahl, P. M., Ziegler, R., Tritschler, H., Halliwell, B. B., et al. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00011-8 · Cited by 141
Forsblom, C. M., Sane, T., Groop, P., Tötterman, K. J., Kallio, M., Saloranta, C., Laasonen, L., Summanen, P. A., Lepäntalo, M., Laatikainen, L., et al. (1998) · Diabetologia · doi:10.1007/s001250051062 · Cited by 141
Resnick, H. E., Vinik, A. I., Schwartz, A. V., Leveille, S. G., Brancati, F. L., Balfour, J., & Guralnik, J. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.11.1642 · Cited by 134
Nickander, K. K., McPhee, B. R., Low, P. A., & Tritschler, H. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)00172-4 · Cited by 132
Self-citationCoppini, D. V., Bowtell, P., Weng, C., Young, P. J., & Sönksen, P. H. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00170-5 · Cited by 123
Alpha-lipoic acid provides neuroprotection from ischemia-reperfusion injury of peripheral nerve
Mitsui, Y., Schmelzer, J. D., Zollman, P. J., Mitsui, M., Tritschler, H., & Low, P. A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00017-9 · Cited by 88
Self-citationThe epidemiology of diabetic neuropathy
Shaw, J. E., & Zimmet, P. (1999) · Diabetes reviews · Cited by 77
Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy
Haak, E., Usadel, K. H., Kusterer, K., Amini, P., Frommeyer, R., Tritschler, H., & Haak, T. (2000) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2000-7739 · Cited by 74
In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy.
Androne, L., Gavan, N. A., Vereșiu, I. A., et al. (2000) · PubMed · Cited by 63
Haak, E., Usadel, K. H., Kohleisen, M., Yılmaz, A., Kusterer, K., & Haak, T. (1999) · Microvascular Research · doi:10.1006/mvre.1999.2151 · Cited by 39
Ca, A., Vileikytė, L., Williamson, S., Al, C., & Boulton, A. J. M. (1998) · Diabetes Care · Cited by 38
Ziegler, D., & Luff, D. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)50085-4 · Cited by 26
Self-citation
Cited by
Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Self-citationBoulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Self-citationXu, S., Ilyas, I., Little, P. J., Li, H., Kamato, D., Zheng, X., Luo, S., Li, Z., Liu, P., Han, J., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000096 · Cited by 1,142
Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice
Johansen, J. S., Harris, A. K., Rychly, D. J., & Ergul, A. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-5 · Cited by 1,003
Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential
Shay, K. P., Moreau, R. F., Smith, E. J., Smith, A. R., & Hagen, T. M. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.026 · Cited by 976
Metadata
- Authors
- Ziegler, D., Nowak, H., Kempler, P., Vargha, P., & Low, P. A.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2004-01-30
- Volume
- 21
- Issue
- 2
- Pages
- 114-121
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2152045883
- Cited by
- 551
- References
- 31
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.